Skip to main content

Advertisement

Table 1 Number of oral antidiabetics tablets supplied in the first 12 months of the SNTP Program (free of charge) and in the 12 months before to the Program (copayment system)

From: Access to medicines for diabetes treatment in Brazil: evaluation of “health has no price” program

Medicines ATC Feb. 2010–Jan. 2011 Feb. 2011–Jan. 2012 Percentage of charge
Medicines included in SNTP Program
 Glibenclamide 5 mg A10BB01 158,388,380 262,747,850 65.9
 Metformin 500 mg A10BA02 289,027,638 424,146,878 46.8
 Metformin 850 mg A10BA02 283,321,454 396,338,216 39.9
Medicines not included in SNTP Program
 Single-drug formulations
  Glimepiride 4 mg A10BB12 38,372,010 45,749,970 19.2
  Metformin 1000 mg A10BA02 12,940,380 14,202,110 9.8
  Glimepiride 2 mg A10BB12 63,221,310 67,166,190 6.2
  Glipizide 5 mg A10BB07 1,415,340 1,300,020 −8.2
  Chlorpropamide 250 mg A10BB02 17,151,540 14,763,550 −13.9
Fixed-dose combinations
 Glibenclamide + metformin (1 mg + 500 mg)a A10BD02 25,764,510 22,236,330 −13.7
 Glibenclamide + metformin (5 mg + 500 mg)b A10BD02 41,330,990 36,197,800 −12.4
 Glibenclamide + metformin (2,5 mg + 500 mg)a A10BD02 12,895,200 11,573,430 −10.3
  1. Brazil, February 2010 through January 2012
  2. Adapted from information published [12]
  3. ATC Anatomical therapeutic chemical
  4. a Only one of the combination of drugs is contemplated in the SNTP Program at the same concentration
  5. b Both drugs are included in the combination SNTP Program at the same concentrations